Microbiology
-
Coinfection with influenza A virus enhances SARS-CoV-2 infectivity
This article has 28 authors:Reviewed by ScreenIT
-
Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein
This article has 2 authors:Reviewed by ScreenIT
-
Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1β, Early Predictors of Severe COVID-19
This article has 17 authors:Reviewed by ScreenIT
-
Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection
This article has 10 authors:Reviewed by ScreenIT
-
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry
This article has 20 authors:Reviewed by ScreenIT
-
Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza
This article has 10 authors:Reviewed by ScreenIT
-
Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice
This article has 15 authors:Reviewed by ScreenIT
-
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
This article has 8 authors:Reviewed by ScreenIT
-
Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures
This article has 6 authors:Reviewed by ScreenIT
-
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine
This article has 16 authors:Reviewed by ScreenIT